|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8500 GBX | +6.25% |
|
-.--% | -55.26% |
| 07-14 | WINNERS & LOSERS: Ironveld's plant in production; Headlam revenue down | AN |
| 07-08 | WINNERS & LOSERS: Jet2 record passengers; Victoria agrees refinancing | AN |
| Market Cap | 1.42M 1.91M 1.66M 1.54M 2.68M 182M 2.72M 18.21M 7.15M 90.74M 7.17M 7.01M 304M | P/E 2024 |
-2.47x | P/E 2025 | -3.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27M 1.71M 1.49M 1.38M 2.4M 163M 2.43M 16.3M 6.4M 81.21M 6.42M 6.28M 272M | EV / Sales 2024 |
61,809,222x | EV / Sales 2025 | 76,138,323x |
| Free-Float |
80.32% | Yield 2024 * |
-
| Yield 2025 | - |
| 02-06 | BSF : Proxy Form | PU |
| 02-06 | BSF : Notice of AGM | PU |
| 25-03-06 | BSF : Publication of Prospectus | PU |
| 25-03-06 | BSF : Prospectus | PU |
| 25-02-07 | BSF : Proxy Form | PU |
| 1 day | +6.25% | ||
| 1 month | -17.07% | ||
| 3 months | -57.07% | ||
| 6 months | -57.50% | ||
| Current year | -55.26% |
| 1 week | 0.7 |  | 1 |
| 1 month | 0.7 | | 1.25 |
| Current year | 0.5 | | 4 |
| 1 year | 0.5 | | 4 |
| 3 years | 0.5 | | 14.84 |
| 5 years | 0.5 | | 23.88 |
| 10 years | 0.5 | | 23.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Che Connon
CEO | Chief Executive Officer | 54 | - |
Graham Duncan
DFI | Director of Finance/CFO | 63 | 2022-06-05 |
Ricardo Gouveia
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoffrey Baker
CHM | Chairman | 70 | 2025-12-04 |
Kian Jing Ow
BRD | Director/Board Member | 60 | 2021-08-04 |
Che Connon
BRD | Director/Board Member | 54 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/18/24 | Buy | Chief Financial Officer | 500 | 0.0005% | ||
| 6/18/24 | Buy | Chief Financial Officer | 11,798 | 0.0114% | ||
| 6/18/24 | Buy | Chief Financial Officer | 23,500 | 0.0227% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.25% | -.--% | -58.02% | -91.71% | 1.91M | |
| +3.29% | +16.25% | +39.81% | +2.79% | 76.15B | |
| -2.75% | +48.50% | +48.50% | +48.50% | 47.83B | |
| +2.72% | -9.39% | +17.04% | +176.83% | 48.89B | |
| -3.81% | +7.74% | -54.57% | -54.17% | 41.37B | |
| -2.40% | +0.38% | +58.55% | -24.89% | 29.99B | |
| -2.82% | +1.57% | +59.59% | +87.57% | 24.23B | |
| -5.35% | +1.39% | +85.45% | -53.41% | 21.75B | |
| -1.59% | -3.61% | -11.53% | +150.58% | 19.25B | |
| -0.42% | +2.89% | +74.55% | +128.45% | 17.14B | |
| Average | -1.07% | +1.33% | +25.94% | +37.05% | 32.66B | |
| Weighted average by Cap. | -1.49% | +2.98% | +30.74% | +43.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.06 0.08 0.07 0.06 0.11 7.43 0.11 0.74 0.29 3.7 0.29 0.29 12.4 | 0.05 0.07 0.06 0.06 0.1 6.79 0.1 0.68 0.27 3.38 0.27 0.26 11.33 |
| Net income | -1.67M -2.25M -1.96M -1.82M -3.16M -215M -3.21M -21.47M -8.43M -107M -8.45M -8.27M -359M | -1.11M -1.5M -1.3M -1.21M -2.1M -143M -2.14M -14.3M -5.61M -71.24M -5.63M -5.51M -239M |
| Net Debt | -560K -753K -655K -610K -1.06M -71.91M -1.07M -7.18M -2.82M -35.8M -2.83M -2.77M -120M | -149K -201K -174K -162K -281K -19.15M -286K -1.91M -751K -9.53M -753K -737K -31.97M |
Employees
14
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | GBX 0.8500 | +6.25% | 1,598,870 |
| 26-07-30 | GBX 0.8000 | -.--% | 381,555 |
| 26-07-29 | GBX 0.8000 | -.--% | 2,536,248 |
| 26-07-28 | GBX 0.8000 | -.--% | 1,649,150 |
| 26-07-27 | GBX 0.8000 | -5.88% | 840,168 |
- Stock Market
- Stocks
- BSFA Stock
Select your edition
All financial news and data tailored to specific country editions
